Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction
Open Access
- 16 September 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 13, 922232
Abstract
Most polyphenols can cross blood-brain barrier, therefore, they are widely utilized in the treatment of various neurodegenerative diseases (ND). Resveratrol, a natural polyphenol contained in blueberry, grapes, mulberry, etc., is well documented to exhibit potent neuroprotective activity against different ND by mitochondria modulation approach. Mitochondrial function impairment is the most common etiology and pathological process in various neurodegenerative disorders, viz. Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis. Nowadays these ND associated with mitochondrial dysfunction have become a major threat to public health as well as health care systems in terms of financial burden. Currently available therapies for ND are limited to symptomatic cures and have inevitable toxic effects. Therefore, there is a strict requirement for a safe and highly effective drug treatment developed from natural compounds. The current review provides updated information about the potential of resveratrol to target mitochondria in the treatment of ND.Keywords
This publication has 248 references indexed in Scilit:
- Enhancement of mitochondrial biogenesis with polyphenols: combined effects of resveratrol and equol in human endothelial cellsImmunity & Ageing, 2013
- Sirtuin deacetylases in neurodegenerative diseases of agingCell Research, 2013
- Mitochondrial Ca2+ and neurodegenerationCell Calcium, 2012
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial FunctionCell Metabolism, 2012
- Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Mitochondrial calcium homeostasis as potential target for mitochondrial medicineMitochondrion, 2012
- The AMPK signalling pathway coordinates cell growth, autophagy and metabolismNature Cell Biology, 2011
- Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory networkBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Oxidative stressBest Practice & Research Clinical Obstetrics & Gynaecology, 2011
- Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol MetabolitesJournal of Medicinal Chemistry, 2010